Increasing Pneumocystis pneumonia, England, UK, 2000-2010
about
Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis RecommendationsEvaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic reviewEpidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literatureEuropean monitoring systems and data for assessing environmental and climate impacts on human infectious diseasesPneumocystis jirovecii pneumonia in Latin America. A public health problem?Structural aspects of intermolecular interactions in the solid state of 1,4-dibenzylpiperazines bearing nitrile or amidine groupsPneumocystis-Driven Inducible Bronchus-Associated Lymphoid Tissue Formation Requires Th2 and Th17 ImmunityInfectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients.Population-based analysis of invasive fungal infections, France, 2001-2010.Pneumocystis jiroveci outbreak in a renal transplant center: Lessons learntPathological and protective immunity to Pneumocystis infection.Cellular profiles of bronchoalveolar lavage fluid and their prognostic significance for non-HIV-infected patients with Pneumocystis jirovecii pneumonia.Eosinophils Contribute to Early Clearance of Pneumocystis murina Infection.Management of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak.Performances of Four Real-Time PCR Assays for Diagnosis of Pneumocystis jirovecii Pneumonia.The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis.Epidemiological Outbreaks of Pneumocystis jirovecii Pneumonia Are Not Limited to Kidney Transplant Recipients: Genotyping Confirms Common Source of Transmission in a Liver Transplantation UnitA protracted course of Pneumocystis pneumonia in the setting of an immunosuppressed child with GMS-negative bronchoalveolar lavageIntermittent Courses of Corticosteroids Also Present a Risk for Pneumocystis Pneumonia in Non-HIV PatientsDiagnosis and management of Pneumocystis jirovecii infection.Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii.Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression.Immunosuppression for ipilimumab-related toxicity can cause pneumocystis pneumonia but spare antitumor immune control.The lung microbiome in patients with pneumocystosis.New advances in understanding the host immune response to Pneumocystis.Pneumocystis and Pneumocystosis: first meeting of experts from Latin-American and Portuguese-speaking countries - a mini-review.Pneumocystis and interactions with host immune receptors.Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.
P2860
Q26781920-41AB35E1-17AD-4EA6-9004-7C8657BBE44FQ26865669-B924FA3E-AFF8-4DF4-8E90-85D1F4310801Q28082149-A4354CED-3083-4A03-BDBE-28FD95FB2F40Q28660010-08B4F742-6CB8-4590-A634-C37848F7F1A4Q30431684-A66E591D-02CB-4016-B91C-D259BBFAEA93Q30856957-7AF3FB59-BFD4-4DC3-9A12-E698726EAAC1Q33620933-AABE2ACC-0660-4ABE-9D05-67D71910B148Q33688400-C7D9079F-007B-4788-A27F-6A893AB48551Q33816423-65BE7950-8413-46DD-8BF3-C5A1ABCBCAB6Q34186416-D26B99F6-30A5-49D5-A5D5-BB64523B3495Q35084980-B46A9750-6249-4262-AC23-F840D19ECA5EQ35193298-4CB37846-4D82-457D-9B1B-255771B46064Q35763497-1FE427A5-F76F-4D66-AB00-B142F68FD5EBQ36288984-4AABE601-A6C7-4DB6-B444-64413B139C96Q36620917-8D6815D5-E110-49E3-B29E-C3BD85AF7197Q36772325-B80A7F07-A697-4675-81F4-DF367717A475Q36834775-1B1857D8-7C54-4680-84C2-4D2CE5016F6FQ36871231-C579A7B0-DE5A-4326-94D9-B21012673BE2Q37303198-4CA2BCFB-A2B8-427C-A2AC-C5D82DC6A246Q40297079-200522A1-D53C-40D8-8554-8C2EEC93948EQ40392438-4F1D4E4F-F5CA-4EEF-AEC6-F779ABDD8B38Q40396288-99C99619-1FD1-4B17-B6B8-3B16E2E71E27Q40959994-B1531A7F-D089-47BA-A536-EF2DC00A7B05Q46248528-1B2F4E5C-8FF2-4EA7-BB40-01878346E8F1Q46516900-729EE9E0-865B-4212-B949-2E5F78CE5DFDQ46627044-03918B14-DC8B-41C0-B1DC-317FFB9E4562Q53702897-9F5F0500-D701-4119-95A4-56814967B84CQ54534916-662DAB13-D5C2-46A1-A0B2-FD5B0ECA39D6
P2860
Increasing Pneumocystis pneumonia, England, UK, 2000-2010
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Increasing Pneumocystis pneumonia, England, UK, 2000-2010
@en
type
label
Increasing Pneumocystis pneumonia, England, UK, 2000-2010
@en
prefLabel
Increasing Pneumocystis pneumonia, England, UK, 2000-2010
@en
P2093
P2860
P356
P1476
Increasing Pneumocystis pneumonia, England, UK, 2000-2010
@en
P2093
Elizabeth A Sheridan
Gordon Nichols
Katherine L Henderson
Rishma Maini
Theresa Lamagni
Valerie Delpech
P2860
P304
P356
10.3201/EID1903.121151
P577
2013-03-01T00:00:00Z